Hun-Taek Kim

USPTO Granted Patents = 15 (Patent Applications = 7)

CIPO Patents = 11 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 14)

Average Co-Inventor Count = 7.1

ph-index = 4

Forward Citations = 114(Granted Patents)

Company Filing History:

9 out of 199

Sk Chemicals Co., Ltd.

Ewha University-Industry Collaboration Foundation

Sunkyong Industries Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12227513 - Salt and crystalline form of furopyrimidine compound and pharmaceutical use thereof (2025-02-18),

2. 10696960 - Fusion protein having factor VII activity (2020-06-30),

3. 10155763 - 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors (2018-12-18),

4. 9987339 - Pharmaceutical composition with improved stability containing factor VII fusion protein (2018-06-05),

5. 9926361 - Process for producing and purifying factor VIII and its derivatives (2018-03-27),

6. 9644197 - Fusion protein having factor VII activity (2017-05-09),

7. 9622986 - Percutaneous absorption preparation containing donepezil, and method for preparing same (2017-04-18),

8. 9617328 - Fusion protein having factor IX activity (2017-04-11),

9. 9481684 - Gonadotropin releasing hormone receptor antagonists, method for the preparation thereof and pharmaceutical composition comprising the same (2016-11-01),

10. 9441030 - Process for producing and purifying factor VIII and its derivatives (2016-09-13),

11. 8420685 - 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors (2013-04-16),

12. 8410146 - 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors (2013-04-02),

13. 7407958 - 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors (2008-08-05),

14. 7041635 - Factor VIII polypeptide (2006-05-09),

15. 5889013 - Pyrimidine acyclonucleoside derivatives (1999-03-30),

Title: Innovator Spotlight: Hun-Taek Kim

Introduction

Hun-Taek Kim is a distinguished inventor based in Seoul, South Korea, known for his contributions to the pharmaceutical field. With a portfolio of 15 patents, he has made significant advancements in the development of innovative compounds and therapeutic proteins.

Latest Patents

Among his latest patents is the invention of salts and crystalline forms of a furopyrimidine compound, which are recognized for their excellent physicochemical properties, including hygroscopicity, chemical stability, and suitability for pharmaceutical applications. This innovation involves a pharmaceutical composition consisting of a specific amino acid compound that serves as an active ingredient. Another notable patent focuses on a fusion protein that demonstrates enhanced factor VII activity compared to existing alternatives. This fusion protein, comprising factor VII and transferrin, shows promise for use in therapies involving factor VII, contributing to improved treatment options.

Career Highlights

Throughout his career, Hun-Taek Kim has collaborated with prominent companies such as Sk Chemicals Co., Ltd. and Tiumbio Co., Ltd. His work at these organizations has led to innovative developments in pharmaceutical technologies, showcasing his expertise in the field.

Collaborations

Hun-Taek has worked closely with industry experts such as Bong-Yong Lee and Dae-Kee Kim. Their collaboration has likely contributed to the success of various projects, further enhancing the quality and efficacy of the inventions that emerge from their joint efforts.

Conclusion

Hun-Taek Kim stands out as a prolific inventor whose patents continue to influence the pharmaceutical landscape. His innovative approaches to drug development and therapeutic solutions underscore the importance of ongoing research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.